De Simone A.; Naldi M.; Tedesco D.; Bartolini M.; Davani L.; Andrisano V., Advanced analytical methodologies in Alzheimer's disease drug discovery, «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2020, 178, Article number: 112899, pp. 1 - 25 [articolo]
Pérez-Areales, F Javier; Garrido, María; Aso, Ester; Bartolini, Manuela; De Simone, Angela; Espargaró, Alba; Ginex, Tiziana; Sabate, Raimon; Pérez, Belén; Andrisano, Vincenza; Puigoriol-Illamola, Dolors; Pallàs, Mercè; Luque, F Javier; Loza, María Isabel; Brea, José; Ferrer, Isidro; Ciruela, Francisco; Messeguer, Angel; Muñoz-Torrero, Diego, Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6, «JOURNAL OF MEDICINAL CHEMISTRY», 2020, 63, pp. 9360 - 9390 [articolo]Open Access
Rozálie Peřinová; Negar Maafi; Jan Korábečný; Eliška Kohelová; Angela De Simone; Abdullah Al Mamun; Daniela Hulcová; Jana Marková; Tomáš Kučera; Daniel Jun; Marcela Šafratová; Jana Maříková; Vincenza Andrisano; Jaroslav Jenčo; Jiří Kuneš; Ana Martinez; Lucie Nováková; Lucie Cahlíková;, Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer's disease, «BIOORGANIC CHEMISTRY», 2020, 100, Article number: 103928, pp. 1 - 10 [articolo]
Verardi L.; Fiori J.; Andrisano V.; Locatelli A.; Morigi R.; Naldi M.; Bertucci C.; Strocchi E.; Boga C.; Micheletti G.; Calonghi N., Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth, «MOLECULES», 2020, 25, Article number: 4438, pp. 1 - 15 [articolo]Open Access
Catanzaro E.; Betari N.; Arencibia J.M.; Montanari S.; Sissi C.; De Simone A.; Vassura I.; Santini A.; Andrisano V.; Tumiatti V.; De Vivo M.; Krysko D.V.; Rocchi M.B.L.; Fimognari C.; Milelli A., Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2020, 202, Article number: 112504, pp. 1 - 10 [articolo]Open Access
Perez-Areales F.J.; Turcu A.L.; Barniol-Xicota M.; Pont C.; Pivetta D.; Espargaro A.; Bartolini M.; De Simone A.; Andrisano V.; Perez B.; Sabate R.; Sureda F.X.; Vazquez S.; Munoz-Torrero D., A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2019, 180, pp. 613 - 626 [articolo]
Hulcova D.; Marikova J.; Korabecny J.; Hostalkova A.; Jun D.; Kunes J.; Chlebek J.; Opletal L.; De Simone A.; Novakova L.; Andrisano V.; Ruzicka A.; Cahlikova L., Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease, «PHYTOCHEMISTRY», 2019, 165, Article number: 112055, pp. 112055 - 112063 [articolo]
De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martini C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A., Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507), «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 1357 - 1357 [articolo]
De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A., Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease., «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 469 - 474 [articolo]Open Access
De Simone, Angela*; Naldi, Marina; Bartolini, Manuela; Davani, Lara; Andrisano, Vincenza, Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018, «CHROMATOGRAPHIA», 2019, 82, pp. 425 - 441 [articolo]
De Simone A.; Naldi M.; Tedesco D.; Milelli A.; Bartolini M.; Davani L.; Widera D.; Dallas M.L.; Andrisano V., Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts, «ACS OMEGA», 2019, 4, pp. 12308 - 12318 [articolo]Open Access
Hostalkova, A.; Marikova, J.; Opletal, L.; Korabecny, J.; Hulcova, D.; Kunes, J.; Novakova, L.; Perez, D. I.; Jun, D.; Kucera, T.; Andrisano, V.; Siatka, T.; Cahlikova, L., Isoquinoline alkaloids from berberis vulgaris as potential lead compounds for the treatment of alzheimer's disease, «JOURNAL OF NATURAL PRODUCTS», 2019, 82, pp. 239 - 248 [articolo]
Heider F.; Pantsar T.; Kudolo M.; Ansideri F.; De Simone A.; Pruccoli L.; Schneider T.; Goettert M.I.; Tarozzi A.; Andrisano V.; Laufer S.A.; Koch P., Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks, «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 1407 - 1414 [articolo]
de simone a, naldi m, tedesco d, bartolini m, andrisano v, A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study., in: 10° MS pharma day book of abstracts, 2018, pp. 15 - 16 (atti di: 10° MS pharma day, Colleretto Giacosa (TO), 24-26 Ottobre) [Contributo in Atti di convegno]
Andrisano, Vincenza*; Naldi, Marina; De Simone, Angela; Bartolini, Manuela, A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017, «EXPERT OPINION ON THERAPEUTIC PATENTS», 2018, 28, pp. 455 - 465 [articolo]
